News

Vanderbilt University researchers have joined a multi-center effort led by Pennsylvania-based Inovio Pharmaceuticals Inc. to accelerate development of potential antibody therapies against the often-lethal Ebola virus.

University of Georgia entomologists have unlocked one of the hormonal mechanisms that allow mosquitoes to produce eggs. The results provide insight into how reproduction is regulated in female mosquitoes, which transmit agents that cause malaria and other diseases in humans and domestic animals. Their work was published in the April edition of the Proceedings of the National Academy of Sciences.

An interdisciplinary team from the University of Texas Medical Branch at Galveston and Profectus BioSciences, Inc. has developed a quick-acting vaccine that is both safe and effective with a single dose against the Ebola strain that killed thousands of people in West Africa last year. These findings are detailed in the new edition of Nature.

When a whole country's public health is at stake, making the wrong policy choices can cost lives and money. That's why researchers have worked to develop computer simulations of epidemics that can model individual behaviors and interactions to predict the spread of disease and the efficacy of interventions.

Consumers are one step closer to benefiting from packaging that could give simple text warnings when food is contaminated with deadly pathogens like E. coli and Salmonella, and patients could soon receive real-time diagnoses of infections such as C. difficile right in their doctors’ offices, saving critical time and trips to the lab. Researchers at McMaster University have developed a new way to print paper biosensors, simplifying the diagnosis of many bacterial and respiratory infections.